Over the years, BioSpherix® has worked with many cell researchers and scientists to uncover the benefits of culturing and processing cells in a physiologic environment. This led to the creation of the Xvivo System® platform, allowing entire protocols to be conducted in an aseptic, uninterrupted, and optimized way.
Since it’s founding in 1982, BioSpherix, Ltd. has supplied cytocentric equipment and systems to a continuously growing customer base in academic, research, pharmaceutical and biotechnology organizations throughout the world. The Xvivo GMP System platform offers many benefits for cell and gene therapies as customers move life-changing discoveries to the clinic.
The Xvivo System® is the first Cytocentric® isolator, the only barrier isolator designed for cells. The modular design can aseptically close any cell production process, small or large, simple or complex, manual or automated. All analytic, automation, and process equipment can be ergonomically integrated.
In 2014, BioSpherix Medical®, located in Parish, NY, was established to accommodate the demand for a vast array of cell culture lab equipment for cell research and cell/gene therapies.
It pays to understand how Cytocentricity benefits cell research and can help stretch your research money. Maximize predictive accuracy and throughput of industrialized cell-based assays, and minimize costs by assuring the quantity, quality, and consistency of cells needed, and the relevancy of the information generated.